Spatial heterogeneity and prognostic value of tertiary lymphoid structures in peritumoral inflammation and tumor beds after neoadjuvant immunochemotherapy for resectable NSCLC
Cellular Oncology · 09.09.2026
DOI: 10.1007/s13402-026-01287-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 09.09.2026. Verfasst von Mei Xie und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xie, M., Gao, J., Zhang, Y., Zhang, X., Deng, H., Xu, T., Shi, W., Yao, J., Jing, Y., & Xue, X. (2026). Spatial heterogeneity and prognostic value of tertiary lymphoid structures in peritumoral inflammation and tumor beds after neoadjuvant immunochemotherapy for resectable NSCLC. Cellular Oncology. https://doi.org/10.1007/s13402-026-01287-2
Vancouver
Xie M, Gao J, Zhang Y, Zhang X, Deng H, Xu T, et al. Spatial heterogeneity and prognostic value of tertiary lymphoid structures in peritumoral inflammation and tumor beds after neoadjuvant immunochemotherapy for resectable NSCLC. Cellular Oncology. 2026. doi:10.1007/s13402-026-01287-2
BibTeX
@article{Xie2026,
author = {Xie, Mei and Gao, Jie and Zhang, Yinguang and Zhang, Xin and Deng, Hui and Xu, Tao and Shi, Weiwei and Yao, Jiannan and Jing, Ying and Xue, Xinying},
title = {Spatial heterogeneity and prognostic value of tertiary lymphoid structures in peritumoral inflammation and tumor beds after neoadjuvant immunochemotherapy for resectable NSCLC},
journal = {Cellular Oncology},
year = {2026},
doi = {10.1007/s13402-026-01287-2}
}
EUVIMED